Johnson & Johnson Delivers Solid -- Not Spectacular -- Earnings

Johnson & Johnson (JNJ) reported 19% lower earnings due to an expected massive restructuring charge -- its biggest ever. But excluding these items, the maker of Tylenol and Band-Aid earned $2.8 billion, or $1.02 per share, beating analyst estimates of 97 cents per share. For the full year, earnings per share were $4.63, beating the $4.55 analysts had expected.